Atlas Trials

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Clinical trial NCT02492217 · COMPLETED

Trial details

NCT number
NCT02492217
Sponsor
Universidade Nova de Lisboa
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ankylosing Spondylitis
Start date
2015-05-01
Primary completion
2018-05-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.